Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 30, Supplement - Infectious Diseases and Carceral Health

SUPPLEMENT ISSUE
Prevention

HIV Care Continuum and Preexposure Prophylaxis Program in Federal Bureau of Prisons, United States

Xiao Hong Huang, Elizabeth Thompson, and Tami RodriguezComments to Author 
Author affiliation: US Public Health Service, Federal Bureau of Prisons, Washington, DC, USA

Main Article

Table

Prevalence of self-reported HIV risk factors during intake screening in study of HIV care and preexposure prophylaxis program in the Federal Bureau of Prisons, April 1, 2021–May 25, 2023*

Risk factors† No. (%) reporting a risk behavior
History of STI‡
40,139 (13.2)
Intravenous drug use 20,287 (6.7)
   IV drug use with needles
7,693 (2.5)
Sexual risk factors
259,843 (85.5)
Condom use
Sometimes 146,665 (48.3)
Never
111,592 (36.7)
Sexual contact with HIV-positive person 1,586 (0.5)

*Total number of intakes was 303,817. Intake screening is performed each time an adult in custody enters a new facility. Because persons in Federal Bureau of Prisons custody often move between facilities, an intake might have been completed for the same patient >1 time during this period. IV, intravenous; STI, sexually transmitted infection. †Federal Bureau of Prisons guidance identifies risk factors that might indicate an HIV-negative patient is at high risk for HIV infection upon release, such as vaginal or anal sex 6 months before or at any time during incarceration and HIV-positive partner, inconsistent use of condoms with partner(s) of unknown HIV status or at high risk for HIV, sex while using drugs, >1 sex partner, STI diagnosis 6 months before or at any time during incarceration, and shared needles for IV drug use 6 months before or at any time during incarceration or might engage in IV drug use upon release. ‡Includes syphilis, genital warts, chlamydia, gonorrhea, and herpes.

Main Article

Page created: March 31, 2024
Page updated: March 31, 2024
Page reviewed: March 31, 2024
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external